Cyclic variations of 3-quinolinecarboxamides and effects on antiherpetic activity.
Supported by the antiherpetic properties of 3-quinolinecarboxamides and the importance of the planar intramolecular H-bonded beta-keto amide pharmacophore, a series of novel conformationally rigid analogues that contain a heterocyclic bridge between the 3- and 4-positions of the quinoline ring have been evaluated. Two isoxazolo-fused derivatives 17 and 23 displayed good in vitro antiherpetic potency that was similar to that of 1, the 3-quinolinecarboxamide that served as the comparison structure for this study. The pyrazolo, pyrrolo, and pyrimido derivatives showed considerably less or no activity. In vitro activity did not translate to in vivo efficacy. For 17, the lack of in vivo activity is likely a consequence of insufficient plasma drug levels (both Cmax and duration) in mice relative to the MIC versus HSV-2.
Wentland
M P
MP
Department of Medicinal Chemistry, Sterling Winthrop Pharmaceuticals Research Division, Sterling Winthrop Inc., Collegeville, Pennsylvania 19426-0900, USA.
Carlson
J A
JA
Dorff
P H
PH
Aldous
S C
SC
Perni
R B
RB
Young
D C
DC
Woods
M G
MG
Kingsley
S D
SD
Ryan
K A
KA
Rosi
D
D
D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry* / Q000494:pharmacology; D004195:Disease Models, Animal; D006558:Herpes Genitalis / Q000188:drug therapy; D018258:Herpesvirus 2, Human / Q000187:drug effects* / Q000254:growth & development; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D011804:Quinolines / Q000737:chemistry* / Q000494:pharmacology; D010948:Viral Plaque Assay
D000998:Antiviral Agents; D011804:Quinolines